Azione OMGA OMEGA THERAPEUTICS, INC.
Aggiungi a un elenco
Solo clienti o iscritti possono usare questa funzione
AccediRegistrati

Altre lingue Omega Therapeutics, Inc.

Azioni

OMGA

US68217N1054

Mercato chiuso - Nasdaq
Altri mercati azionari
 22:00:00 05/07/2024 		Variaz. 5gg Var. 1 gen.
1,78 USD -5,82% Grafico intraday di Omega Therapeutics, Inc. -14,01% -40,86%
24/06 Omega Therapeutics, Inc. nomina Richard N. Kender nel Consiglio di Amministrazione CI
18/06 OMEGA THERAPEUTICS, INC. : giudizio positivo da Raymond James ZM

Altre lingue

Ricerca
Vedi i risultati
Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!
Registrazione 100% gratuita
Omega Therapeutics, Inc.(NasdaqGS:OMGA) dropped from Russell 2000 Growth Index
Omega Therapeutics, Inc.(NasdaqGS:OMGA) dropped from Russell 2500 Index
Omega Therapeutics, Inc.(NasdaqGS:OMGA) dropped from Russell 3000 Index
Omega Therapeutics, Inc.(NasdaqGS:OMGA) dropped from Russell 2000 Index
Omega Therapeutics, Inc.(NasdaqGS:OMGA) dropped from Russell 3000 Growth Index
Omega Therapeutics, Inc.(NasdaqGS:OMGA) dropped from Russell Small Cap Comp Growth Index
Omega Therapeutics, Inc.(NasdaqGS:OMGA) dropped from Russell 2000 Dynamic Index
Omega Therapeutics, Inc.(NasdaqGS:OMGA) dropped from Russell 3000E Growth Index
Omega Therapeutics, Inc.(NasdaqGS:OMGA) dropped from Russell Small Cap Completeness Index
Omega Therapeutics, Inc.(NasdaqGS:OMGA) dropped from Russell 3000E Index
Omega Therapeutics, Inc.(NasdaqGS:OMGA) dropped from Russell 2500 Growth Index
Omega Therapeutics Announces Election of Richard N. Kender to Board of Directors
Omega Therapeutics, Inc. Appoints Richard N. Kender to Board of Directors
Flagship Pioneering and ProFound Therapeutics Announce Agreement to Identify Novel First-in-Class Therapeutics for the Treatment of Obesity under Strategic Partnership with Pfizer
Omega Therapeutics, Inc. Announces Termination of Yan Moore as Chief Medical Officer
Omega Therapeutics To Participate In Two Upcoming Investor Conferences
Omega Therapeutics Appoints Kaan Certel, Ph.D., as Chief Business Officer
Omega Therapeutics, Inc. Appoints Kaan Certel, Ph.D., as Chief Business Officer
Omega Therapeutics Presents New Preclinical Data at ASGCT 2024 Demonstrating Tunable and Durable Upregulation of Gene Expression with Epigenomic Controllers
Omega Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Non ci sono risultati per questa ricerca
Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

Cerca

Data di pubblicazione

Da

A

  1. Borsa valori
  2. Azioni
  3. Azione OMGA
  4. Notizie Omega Therapeutics, Inc.
  5. Altre lingue